List of Chapters/Sections(Table Of Content)
1 Angiotensin II Receptor Blockers Market Overview
1.1 Product Overview and Scope of Angiotensin II Receptor Blockers
1.2 Angiotensin II Receptor Blockers Segment by Type
1.2.1 Global Angiotensin II Receptor Blockers Sales Growth Rate Comparison by Type (2023-2029)
1.2.2 Azilsartan
1.2.3 Candesartan
1.2.4 Eprosartan
1.2.5 Irbesartan
1.2.6 Losartan
1.2.7 Olmesartan
1.2.8 Telmisartan
1.2.9 Valsartan
1.3 Angiotensin II Receptor Blockers Segment by Application
1.3.1 Global Angiotensin II Receptor Blockers Sales Comparison by Application: (2023-2029)
1.3.2 Chronic Kidney Diseases
1.3.3 Heart Failure
1.3.4 Kidney Failure in Diabetes
1.4 Global Angiotensin II Receptor Blockers Market Size Estimates and Forecasts
1.4.1 Global Angiotensin II Receptor Blockers Revenue 2018-2029
1.4.2 Global Angiotensin II Receptor Blockers Sales 2018-2029
1.4.3 Angiotensin II Receptor Blockers Market Size by Region: 2018 Versus 2022 Versus 2029
2 Angiotensin II Receptor Blockers Market Competition by Manufacturers
2.1 Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Angiotensin II Receptor Blockers Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Angiotensin II Receptor Blockers Manufacturing Sites, Area Served, Product Type
2.5 Angiotensin II Receptor Blockers Market Competitive Situation and Trends
2.5.1 Angiotensin II Receptor Blockers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Angiotensin II Receptor Blockers Players Market Share by Revenue
2.5.3 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiotensin II Receptor Blockers Retrospective Market Scenario by Region
3.1 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.3.1 North America Angiotensin II Receptor Blockers Sales by Country
3.3.2 North America Angiotensin II Receptor Blockers Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.4.1 Europe Angiotensin II Receptor Blockers Sales by Country
3.4.2 Europe Angiotensin II Receptor Blockers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Region
3.5.1 Asia Pacific Angiotensin II Receptor Blockers Sales by Region
3.5.2 Asia Pacific Angiotensin II Receptor Blockers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.6.1 Latin America Angiotensin II Receptor Blockers Sales by Country
3.6.2 Latin America Angiotensin II Receptor Blockers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.7.1 Middle East and Africa Angiotensin II Receptor Blockers Sales by Country
3.7.2 Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Angiotensin II Receptor Blockers Historic Market Analysis by Type
4.1 Global Angiotensin II Receptor Blockers Sales Market Share by Type (2018-2023)
4.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2018-2023)
4.3 Global Angiotensin II Receptor Blockers Price by Type (2018-2023)
5 Global Angiotensin II Receptor Blockers Historic Market Analysis by Application
5.1 Global Angiotensin II Receptor Blockers Sales Market Share by Application (2018-2023)
5.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2018-2023)
5.3 Global Angiotensin II Receptor Blockers Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co. Angiotensin II Receptor Blockers Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Angiotensin II Receptor Blockers Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Angiotensin II Receptor Blockers Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Angiotensin II Receptor Blockers Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bayer Angiotensin II Receptor Blockers Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mylan Angiotensin II Receptor Blockers Product Portfolio
6.8.5 Mylan Recent Developments/Updates
7 Angiotensin II Receptor Blockers Manufacturing Cost Analysis
7.1 Angiotensin II Receptor Blockers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Angiotensin II Receptor Blockers
7.4 Angiotensin II Receptor Blockers Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Angiotensin II Receptor Blockers Distributors List
8.3 Angiotensin II Receptor Blockers Customers
9 Angiotensin II Receptor Blockers Market Dynamics
9.1 Angiotensin II Receptor Blockers Industry Trends
9.2 Angiotensin II Receptor Blockers Market Drivers
9.3 Angiotensin II Receptor Blockers Market Challenges
9.4 Angiotensin II Receptor Blockers Market Restraints
10 Global Market Forecast
10.1 Angiotensin II Receptor Blockers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Angiotensin II Receptor Blockers by Type (2023-2029)
10.1.2 Global Forecasted Revenue of Angiotensin II Receptor Blockers by Type (2023-2029)
10.2 Angiotensin II Receptor Blockers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Angiotensin II Receptor Blockers by Application (2023-2029)
10.2.2 Global Forecasted Revenue of Angiotensin II Receptor Blockers by Application (2023-2029)
10.3 Angiotensin II Receptor Blockers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Angiotensin II Receptor Blockers by Region (2023-2029)
10.3.2 Global Forecasted Revenue of Angiotensin II Receptor Blockers by Region (2023-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
